Foamix
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Foamix and buy or sell other stocks, options, and ETFs commission-free!About FOMX
Foamix has a strong in-house pipeline of drugs for dermatologic, ophthalmologic and gynecologic indications. The Company’s lead product under development is the first-in-class Topical Minocycline Foam addressing large markets in dermatology and ophthalmology.
CEODavid Domzalski
CEODavid Domzalski
Employees—
Employees—
HeadquartersRehovot, HaMerkaz
HeadquartersRehovot, HaMerkaz
Founded2003
Founded2003
Employees—
Employees—
FOMX Key Statistics
Market cap184.13M
Market cap184.13M
Price-Earnings ratio-2.30
Price-Earnings ratio-2.30
Dividend yield—
Dividend yield—
Average volume662.94K
Average volume662.94K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$4.84
52 Week high$4.84
52 Week low$1.97
52 Week low$1.97